Oriol Estrada

794 total citations
35 papers, 329 citations indexed

About

Oriol Estrada is a scholar working on Epidemiology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Oriol Estrada has authored 35 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Infectious Diseases and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Oriol Estrada's work include COVID-19 epidemiological studies (6 papers), Chronic Disease Management Strategies (4 papers) and SARS-CoV-2 detection and testing (4 papers). Oriol Estrada is often cited by papers focused on COVID-19 epidemiological studies (6 papers), Chronic Disease Management Strategies (4 papers) and SARS-CoV-2 detection and testing (4 papers). Oriol Estrada collaborates with scholars based in Spain, Israel and Peru. Oriol Estrada's co-authors include Víctor José González Ramallo, Ignacio Blanco, Francesc López Seguí, Carles Forné, Núria Prat, Père Clavé, Bonaventura Clotet, Mariona Aulí, Begoña Lecea and Ricard Farré and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Emerging infectious diseases.

In The Last Decade

Oriol Estrada

29 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oriol Estrada Spain 11 84 73 68 58 47 35 329
Amanda Krosche United States 6 117 1.4× 51 0.7× 30 0.4× 29 0.5× 32 0.7× 8 433
Michael A. Peters United States 11 89 1.1× 67 0.9× 32 0.5× 61 1.1× 43 0.9× 40 378
Edwin Poon China 9 264 3.1× 116 1.6× 41 0.6× 63 1.1× 27 0.6× 9 604
Janine McCready Canada 11 162 1.9× 80 1.1× 82 1.2× 131 2.3× 56 1.2× 22 477
Samah Awad Jordan 10 64 0.8× 100 1.4× 19 0.3× 30 0.5× 45 1.0× 28 404
Rachel Pryor United States 10 125 1.5× 56 0.8× 18 0.3× 52 0.9× 70 1.5× 33 298
Abdullah Algwizani Saudi Arabia 9 105 1.3× 66 0.9× 14 0.2× 43 0.7× 35 0.7× 17 313
Roy Guharoy United States 11 79 0.9× 45 0.6× 55 0.8× 28 0.5× 43 0.9× 36 375
Angela L. Winegar United States 8 160 1.9× 71 1.0× 8 0.1× 98 1.7× 56 1.2× 13 532
Meghan Murray United States 13 82 1.0× 99 1.4× 15 0.2× 64 1.1× 17 0.4× 26 340

Countries citing papers authored by Oriol Estrada

Since Specialization
Citations

This map shows the geographic impact of Oriol Estrada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oriol Estrada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oriol Estrada more than expected).

Fields of papers citing papers by Oriol Estrada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oriol Estrada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oriol Estrada. The network helps show where Oriol Estrada may publish in the future.

Co-authorship network of co-authors of Oriol Estrada

This figure shows the co-authorship network connecting the top 25 collaborators of Oriol Estrada. A scholar is included among the top collaborators of Oriol Estrada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oriol Estrada. Oriol Estrada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roure, Sílvia, Xavier Vallès, Lluís Valerio, et al.. (2025). Therapeutic response to an empirical praziquantel treatment in long-staying sub-Saharan African migrants with positive Schistosoma serology and chronic symptoms: A prospective cohort study in Spain. International Journal of Infectious Diseases. 154. 107873–107873. 2 indexed citations
2.
Estrada, Oriol, et al.. (2025). Analysis of the current status and future vision of innovation in a tertiary hospital in Catalonia: a cross-sectional study. BMC Health Services Research. 25(1). 958–958.
3.
Codina, Pau, Victòria Vilalta, Oriol Estrada, et al.. (2024). Assessing the Impact of Haemodynamic Monitoring with CardioMEMS on Heart Failure Patients: A Cost–Benefit Analysis. ESC Heart Failure. 11(4). 1955–1962. 8 indexed citations
4.
Pelegrí, Josep Lluís, Marta Martín‐Rey, Xavier Vallès, et al.. (2024). Environmental predictors of SARS-CoV-2 infection incidence in Catalonia (northwestern Mediterranean). Frontiers in Public Health. 12. 1430902–1430902.
5.
6.
Mas, Miquel Àngel, et al.. (2023). Machine Learning Model for Predicting Mortality Risk in Patients With Complex Chronic Conditions: Retrospective Analysis. Online Journal of Public Health Informatics. 15. e52782–e52782.
7.
Estrada, Oriol, et al.. (2023). Implementation of a vascular access specialist team in a tertiary hospital: a cost-benefit analysis. Cost Effectiveness and Resource Allocation. 21(1). 67–67. 4 indexed citations
8.
Seguí, Francesc López, Pep Coll, Michael Meulbroek, et al.. (2023). Cost-effectiveness analysis of the daily HIV pre-exposure prophylaxis in men who have sex with men in Barcelona. PLoS ONE. 18(1). e0277571–e0277571. 3 indexed citations
9.
Soldevila, Laura, Núria Prat, Miquel Àngel Mas, et al.. (2022). The interplay between infection risk factors of SARS-CoV-2 and mortality: a cross-sectional study from a cohort of long-term care nursing home residents. BMC Geriatrics. 22(1). 123–123. 14 indexed citations
10.
Seguí, Francesc López, Martí Català, Clara Prats, et al.. (2021). A Cost–Benefit Analysis of COVID-19 Vaccination in Catalonia. Vaccines. 10(1). 59–59. 22 indexed citations
11.
Soldevila, Laura, Sílvia Roure, Miquel Àngel Mas, et al.. (2021). Drug exposure may have a substantial influence on COVID-19 prognosis among residents of long-term care facilities: an exploratory analysis. International Journal of Infectious Diseases. 109. 192–194. 5 indexed citations
12.
13.
Mas, Miquel Àngel, Ramón Miralles, Josep Maria Bonet, et al.. (2021). Designing a Person-Centred Integrated Care Programme for People with Complex Chronic Conditions: A Case Study from Catalonia. International Journal of Integrated Care. 21(4). 22–22. 8 indexed citations
14.
Barallat, Jaume, Gema Fernández‐Rivas, Bibiana Quirant‐Sánchez, et al.. (2020). Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave. PLoS ONE. 15(12). e0244348–e0244348. 26 indexed citations
15.
Torre, Jorge Arias de la, et al.. (2019). Hospitalización domiciliaria sustitutiva del ingreso y facilitadora del alta. Resultados y factores relacionados. Emergencias. 31(6). 440–441. 4 indexed citations
16.
Ramallo, Víctor José González, et al.. (2017). Utilidad de la Hospitalización a Domicilio en las infecciones nosocomiales: ventajas y limitaciones. Revista española de quimioterapia. Suplemento. 30(1). 61–65. 1 indexed citations
17.
Estrada, Oriol, et al.. (2011). Hospitalización a domicilio: oportunidad para el cambio. Medicina Clínica. 138(8). 355–360. 12 indexed citations
18.
Font, Albert, et al.. (2009). Utilidad de la escala de MASCC en el tratamiento de la neutropenia febril inducida por quimioterapia en pacientes con neoplasia sólida. Medicina Clínica. 133(8). 296–299. 2 indexed citations
19.
Ara, Jordi, et al.. (2006). Utilidad de la hospitalización a domicilio en nefrología. Medicina Clínica. 126(9). 329–331. 5 indexed citations
20.
Tudela, Pere, et al.. (2000). Análisis de los avisos internos al equipo de guardia del área médica en un hospital general. Medicina Clínica. 114(19). 730–731. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda Krosche Breakdown of academic impact, for papers by Michael A. Peters Breakdown of academic impact, for papers by Edwin Poon Breakdown of academic impact, for papers by Janine McCready Breakdown of academic impact, for papers by Samah Awad Breakdown of academic impact, for papers by Rachel Pryor Breakdown of academic impact, for papers by Abdullah Algwizani Breakdown of academic impact, for papers by Roy Guharoy Breakdown of academic impact, for papers by Angela L. Winegar Breakdown of academic impact, for papers by Meghan Murray
Rankless by CCL
2026